Vaxart Inc
NASDAQ:VXRT

Watchlist Manager
Vaxart Inc Logo
Vaxart Inc
NASDAQ:VXRT
Watchlist
Price: 0.641 USD -10.26%
Market Cap: 145.8m USD
Have any thoughts about
Vaxart Inc?
Write Note

Vaxart Inc
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Vaxart Inc
Accrued Liabilities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Vaxart Inc
NASDAQ:VXRT
Accrued Liabilities
$8.7m
CAGR 3-Years
16%
CAGR 5-Years
33%
CAGR 10-Years
7%
Abbvie Inc
NYSE:ABBV
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Accrued Liabilities
$14.6B
CAGR 3-Years
16%
CAGR 5-Years
14%
CAGR 10-Years
11%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Accrued Liabilities
$2.5B
CAGR 3-Years
7%
CAGR 5-Years
25%
CAGR 10-Years
24%

See Also

What is Vaxart Inc's Accrued Liabilities?
Accrued Liabilities
8.7m USD

Based on the financial report for Jun 30, 2024, Vaxart Inc's Accrued Liabilities amounts to 8.7m USD.

What is Vaxart Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
7%

Over the last year, the Accrued Liabilities growth was 17%. The average annual Accrued Liabilities growth rates for Vaxart Inc have been 16% over the past three years , 33% over the past five years , and 7% over the past ten years .

Back to Top